Search

everythinglearnresearchcommunity

for

Search:↓

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Antiandrogen therapy helps treat genetic hair loss.

Exemestane may protect bones by stimulating osteoblast growth through androgen-related pathways.

Male pattern baldness is linked to specific genetic variations in the androgen receptor gene.

The piRNA pathway genes are crucial in early development and may influence sex differentiation through hormone regulation.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

VDR gene variations may affect carbohydrate metabolism in young women with hyperandrogenism.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

BMP2 and BMPR-IA may stop hair growth while Noggin may encourage it in yak skin.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

MMP-2 and MMP-9 help hair grow, while their inhibitors peak when hair growth slows.

Paxillin may help manage androgen-related disorders like PCOS by stabilizing androgen receptor proteins.

Early hormones shape sex-specific differences in rat glands.

Targeting CXCL12 may help treat hair loss caused by androgens.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

DHT deficiency increases iNOS expression in rat testis and epididymis.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Natural antioxidants like flavonoids and resveratrol may help prevent low testosterone in aging men.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.